Another company involved in using AI to repurpose failed drugs – as well as drugs that have already been approved – is ...

ALBANY, N.Y., March 17, 2025 (GLOBE NEWSWIRE) -- Curia Global, Inc. (Curia), a leading contract research, development and manufacturing organization, today announced expansion plans to its Glasgow, UK ...

This oversubscribed Series A funding round was led by General Catalyst with additional investment from new investors, British ...

While PD-1/PD-L1 blockade has demonstrated remarkable clinical successes, recent studies suggest that its novel target has a ...

Taiho Pharmaceutical Co., Ltd.Araris Biotech AGTaiho Pharmaceutical to Acquire Next-Generation ADC Drug Discovery Company Araris ...

Having established success in cancer, biopharma is now looking to leverage CAR T therapies against a new target, autoimmune ...

Bayer’s consumer health business benefits from a narrow economic moat, largely because of its strong brand power. Consumers continue to pay a premium for Aspirin, Aleve, and other over-the-counter ...

In a new study reported in Science Advances, scientists analyzed MRI data stored at the UK Biobank and identified seven genes ...

My survival is based on research. With limited NIH funding, I fear that my life, and the lives of others, will be left ...

Federal health officials are tracking a rise in injuries tied to the misuse of laughing gas, including some brands sold in colorful, flavored canisters.

Pacira BioSciences, Inc.'s stock is up 33%, backed by a new Exparel patent, growth strategies, and market trends. Click here ...

Use of cystatin C for chronic kidney disease evaluation and sodium–glucose cotransporter-2 inhibitors as first-line therapy ...